Lipid and fatty acid composition of brain tissue from adrenoleukodystrophy patients
Abstract
White matter and active plaque tissue from adrenoleukodystrophy (ALD) patients were analysed for lipid class and fatty acid compositions and the results compared with white matter from normal brain. ALD white matter was characterised by increased levels of cholesteryl esters and decreased levels of phosphatidylethanolamine, including phosphatidylethanolamine plasmalogen, in comparison with normal brain white matter. In addition to even higher levels of cholesteryl esters, ALD plaque tissue had reduced levels of cerebrosides as well as phosphatidylethanolamines. The loss of phosphatidylethanolamine plasmalogen is indicative of early demyelination. Total lipid from ALD white matter and ALD plaque tissue contained nearly five times and seven times, respectively, more 26:0 than total lipid from normal brain white matter. The 26:0 in ALD white matter was elevated in all lipid classes except phosphatidylinositol, but was located mainly in cerebrosides, phosphatidylcholine, sphingomyelin, and sulfatides. Most of the 26:0 in ALD plaque tissue was present in cholesteryl esters, followed by phosphatidylcholine and sphingomyelin, with reduced amounts in cerebrosides as compared with ALD white matter. The results are consistent with an initial accumulation of very-long-chain fatty acids in ALD white matter, primarily in sphingolipids and phosphatidylcholine, and subsequent accumulation of very-long-chain fatty acids in cholesteryl esters during demyelination. In addition, it was notable that the sphingolipids, especially sphingomyelin in ALD brain, had decreased levels of 24:1 and increased levels of 18:0, as well as increased levels of very-long-chain fatty acids. The extent to which the data shed light on mechanisms of demyelination in ALD is discussed.(ABSTRACT TRUNCATED AT 250 WORDS)
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The white matter and myelin of actively demyelinating areas in cALD show major VLCFA accumulation in glycerolipids, notably phosphatidylcholine (PC) and cholesterol esters (CEs).
“The white matter and myelin of actively demyelinating areas showed major VLCFA accumulation in glycerolipids, notably phosphatidylcholine (PC) and cholesterol esters (CEs).”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [164]
Abnormal VLCFA metabolism precedes demyelination in cALD.
“The authors concluded that abnormal VLCFA metabolism preceded demyelination [163,164] because CE-synthesis enzymes are ten times more active than CE-hydrolysis enzymes [165].”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [164]
White matter areas appearing histologically intact in cALD also show VLCFA accumulation in PC and more limited VLCFA increases in CEs.
“White matter areas appearing histologically intact also showed VLCFA accumulation in PC and more limited VLCFA increases in CEs.”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [164]
Abnormal VLCFA (C > 22) accumulation was first documented in the brains of a young adult and five children with cALD.
“Abnormal VLCFA (C > 22) accumulation was first documented in the brains of a young adult and five children with cALD [163,164].”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [164]
Cites
Fatty acid abnormality in adrenoleukodystrophy
Igarashi, M., Schaumburg, H. H., Powers, J., Kishimoto, Y., Koilodny, E., & Suzuki, K. (1976) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1976.tb04461.x-i1 · Cited by 134 · see citing works
Kishimoto, Y., Moser, H. W., Kawamura, N., Platt, M., Pallante, S. L., & Fenselau, C. (1980) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(80)91182-1 · Cited by 79 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
X-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects
Kemp, S., Berger, J., & Aubourg, P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.03.012 · Cited by 283 · see citing works
Nourooz‐Zadeh, J., Liu, E. H. C., Yhlen, B., Änggåard, E. E., & Halliwell, B. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720734.x · Cited by 187 · see citing works
Plasmalogens participate in very-long-chain fatty acid-induced pathology
Brites, P., Mooyer, P. A. W., el Mrabet, L., Waterham, H. R., & Wanders, R. J. A. (2008) · Brain · doi:10.1093/brain/awn295 · Cited by 112 · see citing works
Singh, J., Khan, M., & Singh, I. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.01.004 · Cited by 21 · see citing works
Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy
Bougnères, P., & Le Stunff, C. (2025) · Genes · doi:10.3390/genes16050590 · Cited by 11 · see citing works
- Authors
- Wilson, R., & Sargent, J. R.
- Affiliations
- University of Stirling (GB)
- Corresponding author
- Wilson, Robert
- ORCID
- Wilson, Robert
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 1993-07
- Volume
- 61
- Issue
- 1
- Pages
- 290-297
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1976030819
- Cited by
- 67
- References
- 2
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 7 · 2023: 2 · 2022: 3 · 2021: 1 · 2020: 2 · 2017: 1 · 2014: 1 · 2013: 5 · 2012: 2
- FWCI
- 1.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Keywords
- adrenoleukodystrophy, brain lipid composition, fatty acid composition, very long chain fatty acids, demyelination, white matter, cholesterol esters, cerebrosides, sphingomyelin, sphingolipids, phosphatidylcholine, sulfatide, phosphatidylinositol
- MeSH terms
- Adrenoleukodystrophy, Brain, Cholesterol Esters, Chromatography, Thin Layer, Densitometry, Fatty Acids, Glycerophosphates, Humans, Male, Phosphatidylcholines, Reference Values, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review